Clinical and Experimental Medicine

, Volume 14, Issue 1, pp 13–24 | Cite as

Therapeutic application of mesenchymal stem cells in bone and joint diseases

Review Article

Abstract

Mesenchymal stem cells (MSCs), the non-hematopoietic progenitor cells, are multi-potent stem cells from a variety of tissues with the capability of self-renewal, proliferation, differentiation into multi-lineage cell types, as well as anti-inflammatory and immunomodulatory. These properties make MSCs an ideal source of cell therapy in bone and joint diseases. This review describes the advances of animal study and preliminary clinical application in the past few years, related to MSC-based cell therapy in the common bone and joint diseases, including osteoarthritis, rheumatoid arthritis, osteoporosis, osteonecrosis of the femoral head and osteogenesis imperfecta. It highlights the promising prospect of MSC in clinical application of bone and joint diseases.

Keywords

Mesenchymal stem cells (MSCs) Osteoarthritis (OA) Osteogenesis imperfecta (OI) Osteoporosis Osteonecrosis of the femoral head (ONFH) Rheumatoid arthritis (RA) 

References

  1. 1.
    Friedenstin AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinetics 3:393–403Google Scholar
  2. 2.
    da Silva ML, Chagatelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204–2213Google Scholar
  3. 3.
    Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396–2402PubMedGoogle Scholar
  4. 4.
    Kim JY, Jeon HB, Yang YS, Oh W, Chang JW (2010) Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. World J Stem Cells 2:34–38PubMedCentralPubMedGoogle Scholar
  5. 5.
    Rodriguez AM, Elabd C, Amri EZ, Aihaud G, Dani C (2005) The human adipose tissue is a source of multipotent stem cells. Biochimie 87:125–128PubMedGoogle Scholar
  6. 6.
    Ilancheran S, Moodley Y, Manuelpillai U (2009) Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta 30:2–10PubMedGoogle Scholar
  7. 7.
    Oh W, Kim DS, Yang YS, Lee JK (2008) Immunological properties of umbilical cord blood-derived mesenchymal stromal cells. Cell Immunol 251:116–123PubMedGoogle Scholar
  8. 8.
    Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM (2002) Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838–3843PubMedGoogle Scholar
  9. 9.
    Ren G, Su J, Zhang L, Zhao X, Ling W, L’huillie A, Zhang J, Lu Y, Roberts AI, Ji W, Zhang H, Rabson AB, Shi Y (2009) Species variation in the mechanisms of mesenchymall stem cell-mediated immunosuppression. Stem Cells 27:1954–1962PubMedGoogle Scholar
  10. 10.
    Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induced T-cell unresponsiveness. Blood 105:2214–2219PubMedGoogle Scholar
  11. 11.
    Gharbi M, Deberg M, Henrotin Y (2011) Application for proteomic techniques in studying osteoarthritis: a review. Front Physiol 2:90PubMedCentralPubMedGoogle Scholar
  12. 12.
    Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM (2011) Homing and reparative effect of intra-articular injection of autologous mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Discord 12:259Google Scholar
  13. 13.
    Aigner T, Rose J, Martin J, Buckwalter J (2004) Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res 7:134–145PubMedGoogle Scholar
  14. 14.
    Mobasheri A (2011) Applications of proteomics to osteoarthritis, a musculoskeletal disease characterized by aging. Front Physiol 2:108PubMedCentralPubMedGoogle Scholar
  15. 15.
    Nöth U, Steinert AF, Tuan RS (2008) Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy: delivery modes for Mesenchymal stem cells. Nat Clin Pract Rheumatol 4:371–380PubMedGoogle Scholar
  16. 16.
    Ameye LG, Young MF (2006) Animal models of osteoarthritis: lessons learned while seeking the ‘Holy Grail’. Curr Opin Rheumatol 18:537–547PubMedGoogle Scholar
  17. 17.
    Liu Y, Shu XZ, Prestwich GD (2006) Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 12:3405–3416PubMedGoogle Scholar
  18. 18.
    Guo X, Wang X, Zhang Y, Xia R, Hu M, Duan C (2004) Repair of large articular cartilage defects with implants of autologous mesenchymal stem cells seeded into beta-tricalcium phosphate in a sheep model. Tissue Eng 10:1818–1829PubMedGoogle Scholar
  19. 19.
    Hui JHP, Chen F, Thambyah A, Lee EH (2004) Treatment of chondral lesions in advanced osteochondritis dissecans: a comparative study of the efficacy of chondrocytes, mesenchymal stem cells, periosteal graft, and mosaicplasty (osteochondral autograft) in animal models. J Pediatr Orthop 24:427–433PubMedGoogle Scholar
  20. 20.
    Yan H, Yu C (2007) Repair of full-thickness cartilage defects with cells of different origin in a rabbit model. Arthroscopy 23:178–187PubMedGoogle Scholar
  21. 21.
    Kayakabe M, Tsutsumi S, Watanabe H, Kato Y, Takagishi K (2006) Transplantation of autologous rabbit BM-derived mesenchymal stromal cells embedded in hyaluronic acid gel sponge into osteochondral defects of the knee. Cytotherapy 8:343–353PubMedGoogle Scholar
  22. 22.
    Kuroda R, Ishida K, Matsumoto T, Akisue T, Fujioka H, Mizuno K (2007) Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone marrow stromal cells. Osteoarthritis Cartilage 15:226–231PubMedGoogle Scholar
  23. 23.
    Lee KBL, Hui JHP, Song IC, Ardany L, Lee EH (2007) Injectable mesenchymal stem cell therapy for large cartilage defects-a porcine model. Stem Cells 25:2964–2971PubMedGoogle Scholar
  24. 24.
    Murphy JM, Fink DJ, Hunziker EB, Barry FP (2003) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48:3464–3474PubMedGoogle Scholar
  25. 25.
    Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM (2011) Homing and reparative effect of intra-articular injection of autologous mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 12:259PubMedCentralPubMedGoogle Scholar
  26. 26.
    Sato M, Uchida K, Nakajima H, Miyazaki T, Guerrero AR, Watanabe S, Roberts S, Baba H (2012) Direct transplantation of mesenchymal stem cells into the knee joints of Hartley Strain guinea pig with spontaneous osteoarthritis. Arthritis Res Ther 14:R31PubMedCentralPubMedGoogle Scholar
  27. 27.
    Horie M, Sekiya I, Muneta T, Ichinose S, Matsumoto K, Saito H, Murakami T, Kobayashi E (2009) Intra-articular injected synovial stem cells differentiate into meniscal cells directly and promote meniscal regeneration without mobilization of distant organs in rat massive meniscal defect. Stem Cells 27:878–887PubMedGoogle Scholar
  28. 28.
    Fan J, Varshney RR, Ren L, Cai D, Wang DA (2009) Synovium-derived mesenchymal stem cells: a new cell source for musculoskeletal regeneration. Tissue Eng Part B Rev 15:75–86PubMedGoogle Scholar
  29. 29.
    Koga H, Shimaya M, Muneta T, Nimura A, Morito T, Hayashi M, Suzuki S, Ju YJ, Mochizuki T, Sekiya I (2008) Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res Ther 10:R84PubMedCentralPubMedGoogle Scholar
  30. 30.
    Vishnubalaji R, Al-Nbaheen M, Kadalmani B, Aldahmash A, Ramesh T (2012) Comparative investigation of the differentiation capability of bone-marrow-and adipose-derived mesenchymal stem cells by qualitative and quantitative analysis. Cell Tissue Res 347:419–427PubMedGoogle Scholar
  31. 31.
    Guilak F, Awad HA, Fermor B, Leddy HA, Gimble JM (2004) Adipose-derived adult stem cells for cartilage tissue engineering. Biorheology 41:389–399PubMedGoogle Scholar
  32. 32.
    Black LL, Gaynor J, Gahring D, Adams C, Aron D, Harman S, Gingerich DA, Harman R (2007) Effect of adipose-derived mesenchymal stem and regenerative cells on lameness in dogs with chronic osteoarthritis of the coxofemoral joints: a randomized, double-blinded, multicenter, controlled trial. Veterinary Therapeutics 8:272–284PubMedGoogle Scholar
  33. 33.
    Black LL, Gaynor J, Adams C, Dhupa S, Sams AE, Taylor R, Harman S, Gingerich DA, Harman R (2008) Effect of intraarticular injection of autologous adipose-derived mesenchymal stem and regenerative cells on clinical signs of chronic osteoarthritis of the elbow joint in dogs. Vet Ther 9:192–200PubMedGoogle Scholar
  34. 34.
    Hou T, Xu J, Wu X, Xie Z, Luo F, Zhang Z, Zeng L (2009) Umbilical cord Wharton’s Jelly: a new potential cell source of mesenchymal stomal cells for bone tissue engineering. Tissue Eng Part A 15:2325–2334PubMedGoogle Scholar
  35. 35.
    Fan CG, Zhang QJ, Zhou JR (2011) Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord. Stem Cell Rev 7:195–207PubMedGoogle Scholar
  36. 36.
    Wang L, Tran I, Seshareddy K, Weiss ML, Detamore MS (2009) A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering. Tissue Eng Part A 15:2259–2266PubMedGoogle Scholar
  37. 37.
    Fong CY, Subramanian A, Gauthaman K, Venugopal J, Biswas A, Ramakrishna S, Bongso A (2012) Human umbilical cord Whaton’s Jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment. Stem Cell Rev 8:195–209PubMedGoogle Scholar
  38. 38.
    Huang K, Zhang C, Zhang XW, Bao JP, Wu LD (2011) Effect of dehydroepiandrosterone on aggrecanase expression in articular cartilage in a rabbit model of osteoarthritis. Mol Biol Rep 38:3569–3572PubMedGoogle Scholar
  39. 39.
    Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knee. Osteoarthritis Cartilage 10:199–206PubMedGoogle Scholar
  40. 40.
    Ohgushi H, Kotobuki N, Funaoka H, Machida H, Hirose M, Tanaka Y, Takakura Y (2005) Tissue engineered ceramic artificial joint-ex vivo osteogenic differentiation of patient mesenchymal cells on total ankle joints for treatment of osteoarthritis. Biomaterials 26:4654–4661PubMedGoogle Scholar
  41. 41.
    Pak J (2011) Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J Med Case Rep 5:296PubMedCentralPubMedGoogle Scholar
  42. 42.
    Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D (2008) Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician 11:343–353PubMedGoogle Scholar
  43. 43.
    Davatchi F, Abdollahi BS, Mohyeddin M, Shahram F, Nikbin B (2011) Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 14:211–215PubMedGoogle Scholar
  44. 44.
    Fournier C (2005) Where do T cells stand in rheumatoid arthritis? Joint Bone Spine 72:527–532PubMedGoogle Scholar
  45. 45.
    Firestein GS (2003) Evolving concepts of rheumatoid arthritis. Nature 423:356–361PubMedGoogle Scholar
  46. 46.
    Gonzalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006–1019PubMedGoogle Scholar
  47. 47.
    Fox DA (1997) The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives. Arthritis Rheum 40:598–609PubMedGoogle Scholar
  48. 48.
    Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2:141–150PubMedGoogle Scholar
  49. 49.
    MacDonal GI, Augello A, De Bari C (2011) Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases. Arthritis Rheum 63(9):2547–2557Google Scholar
  50. 50.
    Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D (2005) Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 52:1595–1603PubMedGoogle Scholar
  51. 51.
    Schurgers E, Kelchtermans H, Mitera T, Geboes L, Matthys P (2010) Discrepancy between the in vitro and in vivo effect of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Therapy 12:R31Google Scholar
  52. 52.
    Chen B, Hu J, Liao L (2010) Flk-1 + mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin Exp Immunol 159:292–302PubMedCentralPubMedGoogle Scholar
  53. 53.
    Augello A, Tasso R, Negrini SM, Cancedda R, Pennesi G (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56:1175–1186PubMedGoogle Scholar
  54. 54.
    GonZalez MA, Gonzalez-Rey E, Rico L, Buscher D, Delgado M (2009) Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006–1019PubMedGoogle Scholar
  55. 55.
    Gonzalez-Rey E, Gonzalez MA, Varela N, O’Valle F, Hernandez-Cortes P, Rico L, Buscher D, Delgado M (2010) Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 69:241–248PubMedGoogle Scholar
  56. 56.
    Zhou B, Yuan J, Zhou Y, Ghawji M Jr, Deng YP, Lee AJ, Lee AJ, Nair U, Kang AH, Brand DD, Yoo TJ (2011) Administering human adipose-derived stem cells to prevent and treat experimental arthritis. Clin Immunol 141:328–337PubMedGoogle Scholar
  57. 57.
    Liu Y, Mu R, Wang S, Long L, Liu X, Li R, Sun J, Guo J, Zhang X, Guo J, Yu P, Li C, Liu X, Huang Z, Wang D, Li H, Gu Z, Liu B, Li Z (2010) Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 12:R210PubMedCentralPubMedGoogle Scholar
  58. 58.
    Choi JJ, Yoo SA, Park SJ, Kang YJ, Kim WU, Oh IH, Cho CS (2008) Mesenchymal stem cells overexpressing interleukin-10 attenuate collagen-induced arthritis in mice. Clin Exp Immunol 153:269–276PubMedCentralPubMedGoogle Scholar
  59. 59.
    Park MJ, Park HS, Cho ML, Oh HJ, Cho YG, Min SY, Chung BH, Lee JW, Kim HY, Cho SG (2011) Transforming growth factor β-transduced mesenchymal stem cells ameliorate experimental autoimmune arthritis through reciprocal regulation of Treg/Th17 cells and osteoclastogenesis. Arthritis Rheum 63:1668–1680PubMedGoogle Scholar
  60. 60.
    Ra JC, Kang SK, Shin IS, Park HG, Joo SA, Kim JG, Kang BC, Lee YS, Nakama K, Piao M, Sohl B, Kurtz A (2011) Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med 9:181PubMedCentralPubMedGoogle Scholar
  61. 61.
    Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L (2012) Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol 31:157–161PubMedGoogle Scholar
  62. 62.
    Peng KY, Horing LY, Sung HC, Huang HC, Wu RT (2011) Antiosteoporotic activity of dioscorea alata L.cv. Phyto through driving mesenchymal stem cells differentiation for bone formation. Evid Based Complement Alternat Med 2011:712892PubMedCentralPubMedGoogle Scholar
  63. 63.
    Raisz LA (2005) Pathogenies of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325PubMedCentralPubMedGoogle Scholar
  64. 64.
    Wang Z, Goh J, De Das S, Ge Z, Ouyang H, Chong JS, Low SL, Lee EH (2006) Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng 12:1753–1761PubMedGoogle Scholar
  65. 65.
    Turgeman G, Aslan H, Gazit Z, Gazit D (2002) Cell-mediated gene therapy for bone formation and regeneration. Curr Opin Mol Ther 4:390–394PubMedGoogle Scholar
  66. 66.
    Bruder SP, Fink DJ, Caplan AI (1994) Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56:283–294PubMedGoogle Scholar
  67. 67.
    Nuttall ME, Patton AJ, Olivera DJ, Nadeau DP, Gowen M (1998) Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: implications for osteopenic disorders. J Bone Miner Res 13:371–382PubMedGoogle Scholar
  68. 68.
    Turgeman G, Zilberman Y, Zhou S, Kelly P, Moutsatsos IK, Kharode YP, Borella LE, Bex FJ, Komm BS, Bodine PV, Gazit D (2002) Systemically administered rh BMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J Cell Biochem 86:461–474PubMedGoogle Scholar
  69. 69.
    Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y, Gazit D (2001) Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl 36(Suppl):144–155PubMedGoogle Scholar
  70. 70.
    Ocarino Nde M, Boeloni JN, Jorgetti V, Gomes DA, Goes AM, Serakides R (2010) Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect Tissue Res 51:426–433PubMedGoogle Scholar
  71. 71.
    Egermann M, Gerhardt C, Barth A, Maestroni GJ, Schnerder E, Alini M (2011) Pinealectomy affects bone mineral density and structure-an experimental study in sheep. BMC Musculoskelet Disord 12:271PubMedCentralPubMedGoogle Scholar
  72. 72.
    Jerome C, Missbach M, Gamse R (2011) Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys. Osteoporos Int 22:3001–3011PubMedGoogle Scholar
  73. 73.
    Tang YC, Tang W, Tian WD, Chen XZ, Li SW (2006) A study on repairing mandibular defect by means of tissue-engineering and human bone morphogenetic protein-2 gene transfection in osteoporotic rats. Zhonghua Kou Qiang Yi Xue Za Zhi 41:430–431PubMedGoogle Scholar
  74. 74.
    Hsiao FS, Cheng CC, Peng SY, Huang HY, Lian WS, Jan ML, Fang YT, Cheng EC, Lee KH, Cheng WT, Lin SP, Wu SC (2010) Isolation of therapeutically functional mouse bone marrow mesenchymal stem cells within 3 h by an effective single-step plastic-adherent method. Cell Prolif 43:235–248PubMedGoogle Scholar
  75. 75.
    Bianco P, Riminucci M, Gronthos S, Robey PG (2001) Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180–192PubMedGoogle Scholar
  76. 76.
    Kanakaris NK, Petsatodis G, Tagil M, Giannoudis PV (2009) Is there a role for bone morphogenetic proteins in osteoporotic fractures? Injury 40(Suppl 3):S21–S26PubMedGoogle Scholar
  77. 77.
    Turgeman G, Pittman DD, Muller R, Kurkalli BG, Zhou S, Pelled G, Peyser A, Ziberman Y, Moutsatsos IK, Gazit D (2001) Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 3:240–251PubMedGoogle Scholar
  78. 78.
    Egermann M, Baltzer AW, Adamaszek S, Evans C, Robbins P, Schneider E, Lill CA (2006) Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Hum Gene Ther 17:507–517PubMedGoogle Scholar
  79. 79.
    Kumar S, Mahendra G, Nagy TR, Ponnazhagan S (2004) Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy. Hum Gene Ther 15:1197–1206PubMedGoogle Scholar
  80. 80.
    Zhang XS, Linkhart TA, Chen ST, Peng H, Wergedal JE, Guttierez GG, Sheng MH, Lau KH, Baylink DJ (2004) Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. J Gene Med 6:4–15PubMedGoogle Scholar
  81. 81.
    Hu J, Qi MC, Zou SJ, Li JH, Luo E (2007) Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats. J Orthop Res 25:241–251PubMedGoogle Scholar
  82. 82.
    Dumon RJ, Dyoub H, Li JZ, Dumont AS, Kallmes DF, Hankins GR, Helm GA (2002) Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 51:1239–1245Google Scholar
  83. 83.
    Kim D, Cho SW, Her SJ, Yang JY, Kim SW, Kim SY, Shin CS (2006) Retrovirus-mediated gene transfer of receptor activator of nuclear factor-kappaB-Fc prevents bone loss in ovariectomized mice. Stem Cells 24:1798–1805PubMedGoogle Scholar
  84. 84.
    Cho SW, Sun HJ, Yang JY, Jung JY, An JH, Cho HY, Choi HJ, Kim SW, Kim SY, Kim D, Shin CS (2009) Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther 17:1979–1987PubMedGoogle Scholar
  85. 85.
    Lien CY, Chih-Yuan Ho K, Lee OK, Blunn GW, Su Y (2009) Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res 24:837–848PubMedGoogle Scholar
  86. 86.
    Chen HT, Lee MJ, Chen CH et al (2012) Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med 16:582–593PubMedGoogle Scholar
  87. 87.
    Wang CJ, Wang FS, Huang CC, Yang KD, Weng LH, Huang HY (2005) Treatment for osteonecrosis of the femoral head: comparison of extracorporeal shock waves with core decompression and bone-grafting. J Bone Joint Surg Am 87:2380–2387PubMedGoogle Scholar
  88. 88.
    Feitosa ML, Fadel L, Beltrao-Braga PC et al (2010) Successful transplant of mesenchymal stem cells in induced osteonecrosis of the ovine femoral head: preliminary results. Acta Cir Bras 25:416–422PubMedGoogle Scholar
  89. 89.
    Chan TW, Dalinka MK, Steinberg ME, Kressel HY (1991) MRI appearance of femoral head osteonecrosis following core decompression and bone grafting. Skeletal Radiol 20:103–107PubMedGoogle Scholar
  90. 90.
    Wassenaar RP, Verburg H, Taconis WK, van der Eijken JW (1996) Avascular osteonecrosis of the femoral head treated with a vascularized iliac bone graft: preliminary results and follow-up with radiography and MR imaging. Radiographics 16:585–594PubMedGoogle Scholar
  91. 91.
    Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop 405:14–23PubMedGoogle Scholar
  92. 92.
    Hernigou P, Manicom O, Poignard A et al (2004) Core decompression with marrow stem cells. Operative Tech Orthop 14:68–74Google Scholar
  93. 93.
    Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, Lambermont M (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am 86-A:1153–1160PubMedGoogle Scholar
  94. 94.
    Wang BL, Sun W, Shi ZC et al (2010) Treatment of nontraumatic osteonecrosis of the femoral head with the implantation of core decompression and concentrated autologous bone marrow containing mononuclear cells. Arch Orthop Trauma Surg 130:859–865PubMedGoogle Scholar
  95. 95.
    Hernigou P, Poignard A, Zilber S, Rouard H (2009) Cell therapy of hip osteonecrosis with autologous bone marrow grafting. Indian J Orthop 43:40–45PubMedCentralPubMedGoogle Scholar
  96. 96.
    GangJi V, De Maertelaer V, Hauzeur JP (2011) Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone 49:1005–1009PubMedGoogle Scholar
  97. 97.
    Hernigou P (1998) Growth factors released from bone marrow are promising tools in orthopedic surgery. Rev Rhum Engl Ed 65:79–84PubMedGoogle Scholar
  98. 98.
    Noel D, Djouad F, Jorgense C (2002) Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 3:1000–1004PubMedGoogle Scholar
  99. 99.
    Kuo TK, Ho JH, Lee OK (2009) Mesenchymal stem cell therapy for nonmusculoskeletal diseases: emerging applications. Cell Transplant 18:1013–1028PubMedGoogle Scholar
  100. 100.
    Cui Q, Xiao Z, Li X, Saleh KJ, Balian G (2006) Use of genetically engineered bone-marrow stem cells to treat femoral defects: an experimental study. J Bone Joint Surg Am 88(Suppl 3):167–172PubMedGoogle Scholar
  101. 101.
    Matsuya H, Kushida T, Asada T, Umeda M, Wada T, Iida H (2008) Regenerative effects of transplanting autologous mesenchymal stem cells on corticosteroid-induced osteonecrosis in rabbits. Mod Rhheumatol 18:132–139Google Scholar
  102. 102.
    Li ZH, Liao W, Cui XL et al (2011) Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head. Int J Med Sci 8:74–83PubMedCentralPubMedGoogle Scholar
  103. 103.
    Yan Z, Hang D, Guo C, Chen Z (2009) Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J Orthop Res 27:442–446PubMedGoogle Scholar
  104. 104.
    Peng J, Wen C, Wang A et al (2011) Micro-CT-based bone ceramic scaffolding and its performance after seeding with mesenchymal stem cells for repair of load-bearing bone defect in canine femoral head. J Biomed Mater Res B Appl Biomater 96:316–325PubMedGoogle Scholar
  105. 105.
    Feitosa ML, Fadel L, Beltrao-Braga PC et al (2010) Successful transplant of mesenchymal stem cells in induced osteonecrosis of the ovine femoral head: preliminary results. Acta Cir Bras 25:416–422PubMedGoogle Scholar
  106. 106.
    Yang J, Wang L, Xu Y, Wang J, Wang Y (2008) An experimental study on treatment of steroid-associated femoral head necrosis with simvastatin and BMSCs transplantation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 22:290–294PubMedGoogle Scholar
  107. 107.
    Wen Q, Zhou L, Zhou C, Zhou M, Luo W, Ma L (2012) Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration. J Cell Mol Med 16:1260–1273PubMedGoogle Scholar
  108. 108.
    Liu BY, Zhao DW (2009) Treatment for osteonecrosis of femoral head by hVEGF-165 gene modified marrow stromal stem cells under arthroscope. Zhonghua Yi Xue Za Zhi 89:2629–2633PubMedGoogle Scholar
  109. 109.
    Zhang C, Wang KZ, Qiang H et al (2010) Angiopoiesis and bone regeneration via co-expression of the hVEGF and hBMP genes from an adeno-associated viral vector in vitro and in vivo. Acta Pharmacol Sin 31:821–830PubMedGoogle Scholar
  110. 110.
    Shi ZB, Wang KZ (2010) Effects of recombinant adeno-associated viral vectors on angiopoiesis and osteogenesis in cultured rabbit bone marrow stem cells via co-expressing hVEGF and hBMP genes: a preliminary study in vitro. Tissue Cell 42:314–321PubMedGoogle Scholar
  111. 111.
    Zhang C, Ma Q, Qiang H, Li M, Dang X, Wang K (2010) Study on effect of recombinant adeno-associated virus co-expressing human vascular endothelial growth factor 165 and human bone morphogenetic protein 7 genes on bone regeneration and angiopoiesis in vivo. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24:1449–1454PubMedGoogle Scholar
  112. 112.
    Tang TT, Lu B, Yue B et al (2007) Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br 89:127–129PubMedGoogle Scholar
  113. 113.
    Xiao ZM, Jiang H, Zhan XL, Wu ZG, Zhang XL (2008) Treatment of osteonecrosis of femoral head with BMSCs-seeded bio-derived bone materials combined with rhBMP-2 in rabbits. Chin J Traumatol 11:165–170PubMedGoogle Scholar
  114. 114.
    Chang T, Tang K, Tao X et al (2010) Treatment of early avascular necrosis of femoral head by core decompression combined with autologous bone marrow mesenchymal stem cells transplantation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24:739–743PubMedGoogle Scholar
  115. 115.
    Zhao D, Cui D, Wang B et al (2012) Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone 50:325–330PubMedGoogle Scholar
  116. 116.
    Pak J (2012) Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads. Pain Physician 15:75–85PubMedGoogle Scholar
  117. 117.
    Byers PH, Wallis GA, Willing MC (1991) Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet 28:433–442PubMedGoogle Scholar
  118. 118.
    Cabral WA, Marini JC (2004) High proportion of mutant osteoblasts is compatible with normal skeletal function in mosaic carriers of osteogenesis imperfecta. Am J Hum Genet 74:752–760PubMedCentralPubMedGoogle Scholar
  119. 119.
    Millington-Ward S, Allers C, Tuohy G et al (2002) Validation in mesenchymal progenitor cells of a mutation-independent ex vivo approach to gene therapy for osteogenesis imperfecta. Hum Mol Gent 11:2201–2206Google Scholar
  120. 120.
    Caplan AI (1995) Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells. Connect Tissue Res 31:S9–S14PubMedGoogle Scholar
  121. 121.
    Pereira RF, O’Hara MD, Laptev AV et al (1998) Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Pro Natl Acad Sci USA 95:1142–1147Google Scholar
  122. 122.
    Guillot PV, Abass O, Bassett JH et al (2008) Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice. Blood 111:1717–1725PubMedGoogle Scholar
  123. 123.
    Horwitz EM, Prockop DJ, Fitzpatrick LA et al (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5:309–313PubMedGoogle Scholar
  124. 124.
    Horwitz EM, Prockop DJ, Gordon PL et al (2001) Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97:1227–1231PubMedGoogle Scholar
  125. 125.
    Horwitz EM, Gordon PL, Koo WK et al (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932–8937PubMedGoogle Scholar
  126. 126.
    Le Blanc K, Gotherstrom C, Ringden O et al (2005) Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patients with severe osteogenesis imperfecta. Transplantation 79:1607–1614PubMedGoogle Scholar
  127. 127.
    Millington-Ward S, McMahon HP, Allen D et al (2004) RNAi of COL1A1 in mesenchymal progenitor cells. Eur J Hum Genet 12:864–866PubMedGoogle Scholar
  128. 128.
    Ljunggren O, Lindahl K, Rubin CJ, Kindmark A (2011) Allele-specific gene silencing in osteogenesis imperfecta. Endocr Dev 21:85–90PubMedGoogle Scholar
  129. 129.
    Jaganathan BG, Bonnet D (2012) Human mesenchymal stromal cells senesce with exogenous OCT4. Cytotherapy 14:1054–1063PubMedGoogle Scholar
  130. 130.
    Symonds CE, Galderisi U, Giordano A (2009) Aging of the inceptive cellular population: the relationship between stem cells and aging. Aging (Albany NY) 1:372–381Google Scholar
  131. 131.
    Galderisi U, Helmbold H, Squillaro T, Alessio N, Komm N, Khadang B, Cipollaro M, Bohn W, Giordano A (2009) In vitro senescence of rat mesenchymal stem cell is accompanied by downregulation of stemness-related and DNA damage repair genes. Stem Cells Dev 18:1033–1042PubMedGoogle Scholar
  132. 132.
    Liu TM, Ng WM, Tan HS, Vinitha D, Yang Z, Fan JB, Zou Y, Hui JH, Lee EH, Lim B (2012) Molecular basis of immortalization of human mesenchymal stem cells by combination of p53 knockdown and human telomerase reverse transcriptase overexpression. Stem Cells Dev Aug 21 [Epub ahead of print]Google Scholar

Copyright information

© Springer-Verlag Italia 2012

Authors and Affiliations

  1. 1.Jinan Pediatric Research InstituteQilu Children’s Hospital of Shandong UniversityJinanChina
  2. 2.Key Laboratory for Biotech-Drugs of the Ministry of Health, Shandong Medicinal Biotechnology CenterShandong Academy of Medical SciencesJinanChina

Personalised recommendations